IPO Details
| Key | Value |
|---|
| IPO Date | September 29, 2025 to October 1, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹181 to ₹191 per share |
| Issue Price Final | ₹191 per share |
| Lot Size | 75 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,20,60,000 shares (aggregating up to ₹230.35 Cr) |
| Employee Discount | ₹9.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 3,23,92,239 shares |
| Share Holding Post Issue | 4,44,52,239 shares |
IPO Subscription Details
| Key | Value |
|---|
| QIB (Ex Anchor) | 2.02 |
| Non-Institutional Buyers | 1.97 |
| bNII (bids above ₹10L) | 1.65 |
| sNII (bids below ₹10L) | 2.60 |
| Retail Investors | 2.09 |
| Employees | 2.01 |
| Total ** | 2.04 |
IPO Important Dates
| Key | Value |
|---|
| IPO Open Date | Mon, Sep 29, 2025 |
| IPO Close Date | Wed, Oct 1, 2025 |
| Tentative Allotment | Fri, Oct 3, 2025 |
| Initiation of Refunds | Mon, Oct 6, 2025 |
| Credit of Shares to Demat | Mon, Oct 6, 2025 |
| Tentative Listing Date | Tue, Oct 7, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Oct 1, 2025 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|
| Retail (Min) | 1 | 75 | ₹14,325 |
| Retail (Max) | 13 | 975 | ₹1,86,225 |
| S-HNI (Min) | 14 | 1,050 | ₹2,00,550 |
| S-HNI (Max) | 69 | 5,175 | ₹9,88,425 |
| B-HNI (Min) | 70 | 5,250 | ₹10,02,750 |
Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 426.56 | 269.24 | 213.86 |
| Total Income | 335.94 | 230.60 | 199.91 |
| Profit After Tax | 46.33 | 27.22 | 21.58 |
| EBITDA | 47.28 | 39.75 | 32.38 |
| NET Worth | 173.11 | 131.88 | 88.96 |
| Reserves and Surplus | 140.72 | 128.94 | 86.18 |
| Total Borrowing | 54.62 | 9.88 | 34.29 |
Information about company
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.
The company designs and delivers turnkey projects, including cleanroom facilities, modular systems, and customized engineering solutions.
It provides end-to-end services such as design, engineering, manufacturing, installation, and project management. With expertise in cleanroom technology, HVAC systems, and process equipment, Fabtech serves global clients, ensuring compliance with international regulatory standards.
Services:
Start-to-Finish: The company helps people in bio-pharma manufacturing life cycle from setting direction right through to taking your products to market.
Clean Water Solutions: The company offer a comprehensive range of equipment for purified water and pure steam generation and distribution as well as water for injections with flow rates ranging from 500 LPH to 50,000 LPH.
Clean Air Solutions: The company supported life sciences, food and beverage, IT, semiconductor, and aeronautics industries with innovative solutions for clean air applications that drive their growth and progress.
As of July 31, 2025, the company had 185 permanent employees.
Competitive Strengths:
A key turnkey engineering solution provider offering integrated engineering solutions with comprehensive service offerings.
In-house software technology capabilities
Diversified order book across geographies, clients, and business verticals.
Project execution across diverse and challenging geographies
Efficient lead funnelling leading to higher mandate conversion
Track record of executing projects across all dosage forms
Experienced Leadership Team with Fabtech Group parentage
Objectives of IPO
The Company Fabtech Technologies IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
S.No.
Objects of the Issue
Expected Amount (₹ in crores)
1
Funding working capital requirements of the Company
127.00
2
Pursuing inorganic growth initiatives through acquisitions
30.00
3
General Corporate Purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | EMP | Total |
|---|
| Day 1
Sep 29, 2025 | 0.77 | 0.46 | 0.36 | 0.65 | 0.71 | 0.54 | 0.70 |
| Day 2
Sep 30, 2025 | 0.94 | 0.76 | 0.56 | 1.16 | 1.20 | 0.96 | 1.01 |
| Day 3
Oct 1, 2025 | 2.02 | 1.97 | 1.65 | 2.60 | 2.09 | 2.01 | 2.04 |
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|
| 04-10-2025 | 191.00 | 0(0.00%) | 191 |
| 03-10-2025 | 191.00 | 0(0.00%) | 191 |
| 02-10-2025 | 191.00 | 0(0.00%) | 191 |
| 01-10-2025 | 191.00 | 0(0.00%) | 191 |
| 30-09-2025 | 191.00 | 0(0.00%) | 191 |
| 29-09-2025 | 191.00 | 2(1.05%) | 193 |
| 28-09-2025 | 191.00 | 20(10.47%) | 211 |
| 27-09-2025 | 191.00 | 35(18.32%) | 226 |
| 26-09-2025 | 191.00 | 35(18.32%) | 226 |
| 25-09-2025 | 191.00 | 35(18.32%) | 226 |
| 24-09-2025 | 191.00 | 0(0.00%) | 191 |
IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|
| QIB Shares Offered | 60,02,527 (49.77%) | NA |
| NII (HNI) Shares Offered | 18,00,758 (14.93%) | NA |
| − bNII > ₹10L | 12,00,505 (9.95%) | 1,143 |
| − sNII < ₹10L | 6,00,253 (4.98%) | 571 |
| Retail Shares Offered | 42,01,769 (34.84%) | 56,023 |
| Employee Shares Offered | 54,945 (0.46%) | NA |
| Total Shares Offered | 1,20,59,999 (100.00%) | |
